Design and evaluation of thin and flexible theophylline imprinted polymer membrane materials.

The aim of this work was to produce a thin, flexible and diffusion able molecularly imprinted polymeric matrix with good template accessibility. Membranes were prepared using a non-covalent molecular imprinting approach and their physical characteristics and binding capabilities investigated. Two materials were used, a poly(tri-ethyleneglycol dimethyacrylate-co-methyl methacrylate-co-methacrylic acid) copolymer containing 14% cross-linker and a monomer (g) to porogen (ml) ratio of 1:0.5 (A), and a blend of poly(TEGMA-co-MAA) and polyurethane (B). The polyurethane was added to improve membrane flexiblity and stability. The polymers were characterized using AFM, SEM and nitrogen adsorption, whilst binding was evaluated using batch-rebinding studies. For all membranes the specific surface area was low (<10 m(2)/g). MIP (A) films were shown to bind specifically at low concentrations but specific binding was masked by non-specific interactions at elevated concentrations. Selectivity studies confirmed specificity at low concentrations. K(D) approximations confirmed a difference in the population of binding sites within NIP and MIP films. The data also indicated that at low concentrations the ligand-occupied binding site population approached homogeneity. Scanning electron microscopy images of membrane (B) revealed a complex multi-layered system, however these membranes did not demonstrate specificity for the template. The results described here demonstrate how the fundamental parameters of a non-covalent molecularly imprinted system can be successfully modified in order to generate flexible and physically tolerant molecularly imprinted thin films.

Improving alginate-poly-L-ornithine-alginate capsule biocompatibility through genipin crosslinking.

DIABECELL® capsules comprise an inner core of alginate (Alg) coated with a polycationic polymer, poly-L-ornithine (PLO), designed as a stabilizing agent for strengthening the capsule wall, which is masked by an outer layer of biocompatible Alg. These polymeric microcapsules have demonstrated excellent mechanical properties and a reduction in hypoglycemia after tranplantation in human clinical trials; however, degradation of the outer Alg layer leaves the underlying layers of PLO exposed, which ultimately leads to reduced biocompatibility in vivo. Here we aim to improve capsule biocompatibility and to increase the hydrophilic properties of the capsule surface through chemical crosslinking/modification of the PLO layer using genipin. Fluorescence microscopy established crosslinking was limited to the layers of PLO. In vitro experiments confirmed islet viability and insulin release within chemically modified capsules over the course of a month and in vivo investigations demonstrated improved biocompatibility when comparing standard Alg/PLO/Alg capsules with genipin modified capsules.

Effect of genipin cross-linking on the cellular adhesion properties of layer-by-layer assembled polyelectrolyte films.

Use of polyelectrolyte multi-layers as biomaterials for cell attachment has been limited due to their gel-like characteristics. Herein, we attempt to improve the cellular adhesion properties of multi-layer films, reduce their gel-like nature and rigidify them through chemical cross-linking with genipin; a natural and non-cytotoxic compound. Chitosan (CH), hyaluronan (HA) and alginate (Alg) were used to assemble [CH-HA]n CH and [CH-Alg]n CH films, and the effects of genipin cross-linking on the cell adhesion properties of these multi-layers were investigated. Atomic force microscopy (AFM) confirmed that cross-linking affected each of the films differently. Quartz crystal microbalance with dissipation (QCM-D) revealed that [CH-HA]10 CH films were very viscoelastic, with thicknesses in the range 350-450 nm, while [CH-Alg]10 CH films only grew to thicknesses of approximately 100 nm. These differences were a result of the different growth regimes of these two polyelectrolyte systems. Cell adhesion studies using MC3T3 pre-osteoblasts and rat fibroblastic skin cells, carried out on both films demonstrated vast differences in cell adhesion. [CH-HA]n CH cross-linked films proved to be highly non-adhesive for pre-osteoblasts and fibroblastic skin cells. Conversely, cross-linking [CH-Alg]n CH films was shown to dramatically improve pre-osteoblast and rat fibroblastic skin cell adhesion, especially for high bi-layer numbers and using higher concentrations of cross-linker.

Biorecognition through layer-by-layer polyelectrolyte assembly: in-situ hybridization on living cells.

Encapsulated cells were formed from the assembly of cationic and anionic alternating layers using a number of polyelectrolyte-based systems. Chitosan, alginate, hyaluronic acid, and oligonucleotides were used as polyelectrolytes to encapsulate individual E. coli cells, which were used as a model. Zeta potential measurements taken for both chitosan/alginate and chitosan/hyaluronic acid systems indicate successful layer-by-layer (LbL) deposition and gave full reversal of the surface change eight times. Layer adsorption was further observed by fluorescence microscopy, and, through a newly developed protocol for sample preparation, transmission electron microscopy micrographs clearly showed the presence of LbL assembly on the outer layer of the cell membrane, in the nanometer range. A second generation of E. coli cells could be grown from encapsulated first generation cells, demonstrating that the cellular activity was not affected by the presence of polyelectrolyte multilayers. Hybridization between attached oligonucleotide sequences and the complementary sequence was demonstrated by both fluorescence spectroscopy and microscopy. Fluorescence energy transfer data recorded after hybrid formation showed that at a molar ratio of 10:20 (donor:acceptor), Q and I were 92.3% and 52.5%, respectively, which suggests that fluorescein fluorescence was quenched by 92.3% and that the fluorescence of rhodamine was enhanced by 52.5%. Oligonucleotide incorporation was stabilized by deposition of four alternating layers, hence offering not only the potential use of the encapsulated cell as a bio-recognition system but also its application in a number of fields such as oligonucleotide delivery, gene therapy, and the use of DNA as an immunocompatible coating.

The type IIs restriction endonuclease BspMI is a tetramer that acts concertedly at two copies of an asymmetric DNA sequence.

Type IIs endonucleases recognize asymmetric DNA sequences and cleave both strands at fixed positions downstream of the sequence. Many type IIs enzymes, including BspMI, cleave substrates with two sites more rapidly than those with one site. They usually act sequentially on DNA with two sites, but BspMI converted such a substrate directly to the final products cut at both sites. The BspMI endonuclease was found to be a tetramer, in contrast to the monomeric structures for many type IIs enzymes. No change in subunit association occurred during the BspMI reaction. Plasmids with two BspMI sites were cleaved in cis, in reactions spanning sites in the same DNA, even when the sites were separated by just 38 bp. Plasmids with one BspMI site were cleaved in trans, with the enzyme bridging sites in separate DNA molecules: these slow reactions could be accelerated by adding a second DNA with the recognition sequence. Thus, whereas many type IIs enzymes dimerize before cleaving DNA, a process facilitated by two recognition sites in cis, the BspMI tetramer binds two copies of its recognition sequence before cleaving the DNA in both strands at both sites.